. the adjuvant they purchased has a bad history
. the adjuvant they purchased has a bad history
It is an unapproved, new adjuvant that was in development years ago and it's the defense department's refusal to investigate problems that turned up following it's supposed nonuse when vaccinating for one of the Iraq wars, along with a track record of causing serious problems for people with allergies or auto-immune disorders (I forget which) that has led to concerns about it. It supposedly was not used in the Iraq vaccinations, but titers related to it turned up in Iraq war vets I think with Iraq war syndrome. Despite one federal depts. concerns that were repeatedly raised, the issue was buried. The pharma involved denied that their vaccine was contaminated with the adjuvant. But there was no other source possible for the titers.
I am a med lab tech student and not anti-vax per se, but after reading how it works from a biochemical/physiological standpoint and reading the history, I decided I would not vax if they used that particular class of adjuvant. The problem is the old, tried and true (and approved) adjuvant interacts with the virions themselves, to make it easier for the immune system to see the virus, so it responds earlier on in the infection. But it only stretches the vax supply a small amount. The new class of adjuvants they are tinkering with are intended to stretch supplies further, but they actually interact with and effect the immune system itself and in many people that can be devastating.
I'll see if I can find the article...it was a real eye-opener.
0 Comments:
Post a Comment
<< Home